Zhejiang Medicine released its first-quarter performance, with a net profit attributable to the parent company of 409 million yuan, a year-on-year increase of 273.08%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, ZMC disclosed its first-quarter report for 2025, showing that the company achieved revenue of 2.255 billion yuan during the reporting period, a year-on-year increase of 0.28%; net profit attributable to the parent company was 409 million yuan, a year-on-year increase of 273.08%; and net profit excluding non-recurring gains and losses was 402 million yuan, a year-on-year increase of 279.23%. Basic earnings per share were 0.43 yuan
According to the Zhitong Finance APP, Zhejiang Medicine (600216.SH) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 2.255 billion yuan, a year-on-year increase of 0.28%; net profit attributable to the parent company was 409 million yuan, a year-on-year increase of 273.08%; and net profit excluding non-recurring gains and losses was 402 million yuan, a year-on-year increase of 279.23%. The basic earnings per share were 0.43 yuan